(Q36727549)

15 August 2017

1 reference

title

Changing perspective on immunization against influenza (English)

1 reference

15 August 2017

0 references

Bert E Johansson

1

1 reference

PubMed ID

17276554

15 August 2017

Ian C Brett

series ordinal

2

1 reference

PubMed ID

17276554

15 August 2017

language of work or name

English

0 references

publication date

19 January 2007

1 reference

15 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

15 August 2017

25

1 reference

15 August 2017

16

1 reference

15 August 2017

3062-3065

1 reference

Host range restriction and pathogenicity in the context of influenza pandemic.

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Preparation and characterization of a purified influenza virus neuraminidase vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.030

10.1016/J.VACCINE.2007.01.030

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17276554